BeyondSpring (BYSI) Stock Highlights

1.71 | -0.58%

2024-11-21 06:00:49

BeyondSpring Inc is engaged in clinical stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. The Company has created Plinabulin which is marine derived small-molecule with a number of distinct biological activities that may provide multiple therapeutic opportunities. Plinabulin has increased the survival of neutrophils, a type of white blood cell important in the prevention of bacterial infections. The Company has a scalable business model integrating clinical resources in the United States and China.

Statistics

Range Today

1.66 1.74

Volume Today 16K

Range 1 Year

0.78 4

Volume 1 Year 21.08M

Range 3 Year

0.54 15.4

Volume 3 Year 264.73M

Range 10 Year

0.54 48.49

Volume 10 Year 591.85M

Highlights

Market Capitalization 78.18M (small)

Floating Shares 25.28M

Current Price 1.71

Price To Earnings -4.66

Price To Revenue 38.07

Earnings Per Share -0.41

Payout Ratio 0%

Performance

Latest -0.58%

1 Month -27.85%

3 Months -14.07%

6 Months -36.67%

1 Year +85.87%

3 Years -87.21%

5 Years -87.4%

10 Years -91.45%

Benchmarks

Market Capitalization

297 / 368

Gross Profits

0 / 278

Total Revenue

230 / 300

Total Rank

34 / 368

Free Cashflow

157 / 352

Performance 5 years

261 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.